GLI
ABBV icon

Guardian Life Insurance’s AbbVie ABBV Stock Holding History

Guardian Life Insurance’s Portfolio ABBV Stock Details ABBV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q1 		– Sell
-4,355
Closed -$386K – 5
2019
Q4 		$386K Buy
4,355
+28
+0.6% +$2.33K 0.09% 51
2019
Q3 		$328K Buy
4,327
+54
+1% +$3.7K 0.05% 72
2019
Q2 		$311K Buy
4,273
+19
+0.4% +$1.49K 0.04% 74
2019
Q1 		$343K Sell
4,254
-35
-0.8% -$2.86K 0.04% 70
2018
Q4 		$395K Buy
4,289
+17
+0.4% +$1.5K 0.07% 51
2018
Q3 		$404K Buy
4,272
+79
+2% +$7.49K 0.07% 52
2018
Q2 		$388K Buy
4,193
+524
+14% +$51.2K 0.07% 50
2018
Q1 		$347K Sell
3,669
-1,493
-29% -$164K 0.06% 47
2017
Q4 		$499K Buy
5,162
+1,537
+42% +$145K 0.11% 49
2017
Q3 		$322K Buy
3,625
+25
+0.7% +$1.9K 0.05% 52
2017
Q2 		$261K Sell
3,600
-2,558
-42% -$172K 0.04% 52
2017
Q1 		$401K Sell
6,158
-69
-1% -$4.34K 0.06% 61
2016
Q4 		$390K Buy
6,227
+185
+3% +$11.3K 0.06% 68
2016
Q3 		$381K Hold
6,042
– – 0.04% 101
2016
Q2 		$374K Sell
6,042
-5
-0.1% -$305 0.03% 125
2016
Q1 		$345K Sell
6,047
-1,712
-22% -$95.4K 0.03% 123
2015
Q4 		$460K Sell
7,759
-1,921
-20% -$111K 0.05% 112
2015
Q3 		$527K Buy
9,680
+2,146
+28% +$140K 0.05% 114
2015
Q2 		$506K Buy
7,534
+563
+8% +$36.8K 0.04% 109
2015
Q1 		$408K Sell
6,971
-2,110
-23% -$127K 0.04% 128
2014
Q4 		$594K Buy
9,081
+35
+0.4% +$2.21K 0.06% 115
2014
Q3 		$522K Buy
+9,046
New +$502K 0.05% 114
2014
Q2 		– Sell
-8,955
Closed -$460K – 570
2014
Q1 		$460K Buy
8,955
+9
+0.1% +$455 0.04% 126
2013
Q4 		$472K Sell
8,946
-10,148
-53% -$499K 0.04% 126
2013
Q3 		$854K Buy
19,094
+72
+0.4% +$3.19K 0.07% 125
2013
Q2 		$786K Buy
+19,022
New +$832K 0.07% 131

Other funds holding ABBV

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

Guardian Life Insurance's ABBV Position: Q1 2020 in Review

Guardian Life Insurance sold out of AbbVie (ABBV) in Q1 2020, closing a stake of 4,355 shares — an estimated $386K sold.

Guardian Life Insurance first reported a position in ABBV in Q2 2013 and held it in 26 quarters. The position peaked at $854K in Q3 2013. 2,225 funds tracked by Wall St. Rank hold ABBV as of Q1 2020.

  • Guardian Life Insurance reported no remaining AbbVie position as of Q1 2020 after selling out during the quarter.
  • Guardian Life Insurance sold 4,355 AbbVie shares in Q1 2020, an estimated $386K.
  • Guardian Life Insurance first reported a position in AbbVie in Q2 2013 and held it in 26 quarters.
  • Guardian Life Insurance's AbbVie position peaked at $854K in Q3 2013.
  • 2,225 funds tracked by Wall St. Rank held AbbVie as of Q1 2020.

Based on Guardian Life Insurance's 13F filing for Q1 2020.